Eclipse Regenesis Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Later Stage VC
- Investors
-
14
Eclipse Regenesis General Information
Description
Developer of a tissue regeneration platform designed for short bowel syndrome treatment. The company's technology offers distraction enterogenesis, tissue regeneration therapy, mechanical intestinal lengthening, implantable device design, minimally invasive endoscopic development, preclinical intestinal modeling, and translational research, enabling short bowel syndrome patients to regrow healthy intestinal tissue naturally to increase nutrient absorption and reduce reliance on lifelong intravenous feeding.
Contact Information
Website
www.eclipseregenesis.comCorporate Office
- Sobrato Pavilion, 2495 Hospital Drive
- Suite 300
- Mountain View, CA 94040
- United States
Corporate Office
- Sobrato Pavilion, 2495 Hospital Drive
- Suite 300
- Mountain View, CA 94040
- United States
Eclipse Regenesis Timeline
Eclipse Regenesis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC | 11-Aug-2025 | Completed | Generating Revenue | |||
| 10. Later Stage VC (Series A) | 25-Apr-2023 | Completed | Generating Revenue | |||
| 9. Grant | 01-Jan-2023 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 15-Aug-2022 | Completed | Generating Revenue | |||
| 7. Grant | 26-Aug-2021 | Completed | Generating Revenue | |||
| 6. Grant | 02-Apr-2021 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 4. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jun-2020 | Completed | Generating Revenue | |||
| 2. Grant | 30-Mar-2020 | $50K | Completed | Generating Revenue |
Eclipse Regenesis Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Eclipse Regenesis Patents
Eclipse Regenesis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026107214-A1 | Plication anchoring devices and systems, hemostasis clips and systems, and methods for using same | Pending | 13-Nov-2024 | ||
| EP-4761676-A1 | Systems and methods for distending a tubular organ and/or enhancing nutrient absorption | Pending | 16-Aug-2023 | ||
| WO-2025038884-A1 | Systems and methods for distending a tubular organ and/or enhancing nutrient absorption | Inactive | 16-Aug-2023 | ||
| AU-2023444280-A1 | Plication systems, plication/spring systems, and methods of use thereof | Pending | 18-Apr-2022 | ||
| EP-4510972-A1 | Plication systems, plication/spring systems, and methods of use thereof | Pending | 18-Apr-2022 | A61F2/04 |
Eclipse Regenesis Signals
Eclipse Regenesis Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Impact Assets | Impact Investing | Minority | ||
| Atacama Ventures | Venture Capital | Minority | ||
| Cloudstone Capital | Venture Capital | Minority | ||
| MainSheet Ventures | Venture Capital | Minority | ||
| SVE Capital | Venture Capital | Minority |
Eclipse Regenesis FAQs
-
When was Eclipse Regenesis founded?
Eclipse Regenesis was founded in 2017.
-
Where is Eclipse Regenesis headquartered?
Eclipse Regenesis is headquartered in Mountain View, CA.
-
What is the size of Eclipse Regenesis?
Eclipse Regenesis has 8 total employees.
-
What industry is Eclipse Regenesis in?
Eclipse Regenesis’s primary industry is Other Devices and Supplies.
-
Is Eclipse Regenesis a private or public company?
Eclipse Regenesis is a Private company.
-
What is Eclipse Regenesis’s current revenue?
The current revenue for Eclipse Regenesis is .
-
How much funding has Eclipse Regenesis raised over time?
Eclipse Regenesis has raised $9.3M.
-
Who are Eclipse Regenesis’s investors?
Impact Assets, Atacama Ventures, Cloudstone Capital, MainSheet Ventures, and SVE Capital are 5 of 14 investors who have invested in Eclipse Regenesis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process